Insist! on Better Care
Biomarker testing in multiple myeloma (MM) is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! Myeloma is to educate and empower patients and care partners to speak up and insist on better care.
This program is supported by Bristol Myers Squibb/Celgene, Foundation Medicine, and Takeda, and through generous donations from people like you.